(BON) Bon Natural Life - Ratings and Ratios

Exchange: NASDAQ • Country: China • Currency: USD • Type: Common Stock • ISIN: KYG144921056

BON: Herbal, Fragrance, Supplements, Food Additives, Nutritional

Bon Natural Life Limited (NASDAQ:BON), established in 2006 and headquartered in Xian, China, specializes in the R&D, production, and distribution of natural herb-derived active ingredients. The company serves various industries including functional foods, personal care, cosmetics, and pharmaceuticals by providing ingredients like fragrances and health supplements. Their product portfolio includes bioactive food ingredients and powder drinks used as nutritional supplements and additives.

With a market capitalization of $3.96M, Bon Natural Life exhibits a P/E ratio of 5.58 and a forward P/E of 2.35, indicating potential undervaluation. The price-to-book ratio of 0.09 and price-to-sales ratio of 0.17 further suggest attractive valuations. The return on equity stands at 10.43%, reflecting efficient equity utilization.

Technically, the stocks average 20-day volume is 24,590, with a last price of $0.92. The SMA 20, 50, and 200 are $1.09, $1.34, and $1.75 respectively, while the ATR is $0.14. This data points to a stock trading below its short and long-term moving averages, signaling a bearish trend with low volatility.

Over the next three months, BON is expected to face downward pressure due to being below key moving averages. The low average volume may lead to high volatility. However, the undervalued fundamentals could attract investors seeking bargains, potentially stabilizing or increasing the stock price slightly, albeit with limited upside due to overall market conditions. The stock is likely to trade within a narrow range near current levels, with potential for modest recovery if market sentiment improves.

Additional Sources for BON Stock

BON Stock Overview

Market Cap in USD 4m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Packaged Foods & Meats
IPO / Inception 2021-06-24

BON Stock Ratings

Growth 5y -85.5%
Fundamental 15.8%
Dividend 0.0%
Rel. Strength Industry -70.6
Analysts -
Fair Price Momentum 0.66 USD
Fair Price DCF -

BON Dividends

No Dividends Paid

BON Growth Ratios

Growth Correlation 3m -87.7%
Growth Correlation 12m -93.8%
Growth Correlation 5y -98.3%
CAGR 5y -65.01%
CAGR/Max DD 5y -0.65
Sharpe Ratio 12m -0.94
Alpha -75.11
Beta 0.49
Volatility 177.72%
Current Volume 83998.1k
Average Volume 20d 80.4k
What is the price of BON stocks?
As of March 17, 2025, the stock is trading at USD 1.44 with a total of 83,998,065 shares traded.
Over the past week, the price has changed by +26.49%, over one month by +11.18%, over three months by -15.29% and over the past year by -68.35%.
Is Bon Natural Life a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Bon Natural Life is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.81 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BON as of March 2025 is 0.66. This means that BON is currently overvalued and has a potential downside of -54.17%.
Is BON a buy, sell or hold?
Bon Natural Life has no consensus analysts rating.
What are the forecast for BON stock price target?
According to ValueRays Forecast Model, BON Bon Natural Life will be worth about 0.7 in March 2026. The stock is currently trading at 1.44. This means that the stock has a potential downside of -50.69%.
Issuer Forecast Upside
Wallstreet Target Price 77.5 5281.9%
Analysts Target Price - -
ValueRay Target Price 0.7 -50.7%